Welcome!

Cognitive Computing Authors: Kelly Burford, Elizabeth White, Kevin Benedict, Liz McMillan, Yeshim Deniz

News Feed Item

Global Proteomics Industry

NEW YORK, Dec. 5, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Global Proteomics Industry

http://www.reportlinker.com/p092466/Global-Proteomics-Industry.html#utm_...

 

This report analyzes the worldwide markets for Proteomics in US$ Million by the following Product Segments: Expression Proteomics, Functional Proteomics, and Structural Proteomics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period of 2010 through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 111 companies including many key and niche players such as ActivX Biosciences, Inc., Adnexus Therapeutics, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bruker Daltonics, Inc., Caprion Proteomics, Inc., Digilab Genomic Solutions, Inc., Dionex Corporation, GE Healthcare, Geneva Bioinformatics S.A., Hybrigenics SA, Life Technologies Corporation, Millipore Corp., PerkinElmer, Inc., Caliper Life Sciences, Shimadzu Biotech, Sigma-Aldrich Corporation, Thermo Fisher Scientific, Waters Corp., Xencor Inc., and Zyomyx, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

 

 

 

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-2

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

Expression Proteomics I-3

Functional Proteomics I-3

Structural Proteomics I-4

 

 

II. EXECUTIVE SUMMARY

 

1. GLOBAL MARKET OVERVIEW II-1

Proteomics - The Current Spotlight II-1

Market Drivers II-1

Transition from Genomics to Proteomics II-1

Industrialization of Proteomics Research II-2

International Initiatives Light-up Proteomics Market II-2

Factors Limiting Market Growth II-2

Economic Recession Impact on the Life Sciences Industry in

Retrospect II-2

Biotechnology Sector - Affected by Collapse of Capital Market II-3

Tough Times for Market Participants II-3

Proteomics Technologies: Growing in Significance II-4

Transformation of Drug Discovery through Proteomics and Genomics II-5

Proteomics: A Critical Drug Discovery Tool II-5

China All Set To Play a Major Role in the Proteomics Industry II-6

Global Proteomics Sample Preparation Market - On a Growth Curve II-7

Challenges Facing Proteomics Sample Preparation Market II-7

Challenges Facing Proteomics Industry II-7

Protein Chemistry and its Complexities II-7

Integration of Data & Equipment II-7

Data Validation - A Burning Issue II-8

Standardization & Consistency - A Prime Concern II-8

Incomplete and Disorganized Data II-8

 

2. INDUSTRY COMPETITION II-9

Industry Participants II-9

Proteomics Market Worldwide: Competitive Landscape II-9

Proteomics Supplier Market II-9

Tool Providers: Leading the Proteomics Market II-10

Applied Biosystems-Invitrogenc Corporation Merger - A Key

Development II-10

Challenges Ahead II-11

Designing a Novel Business Model II-11

Role of Contract Research Organizations - All Set to Increase

in Proteomics II-11

 

3. PRODUCT AND TECHNOLOGY OVERVIEW II-12

Proteins, Proteome and Proteomics!!! - What are They? II-12

Proteomics - An Introduction II-12

Genesis of Proteomics II-13

Tales From Times Gone By II-13

Components of Proteomics II-13

Expression Proteomics II-13

Functional Proteomics II-14

Cell-map Proteomics II-14

Structural Proteomics II-14

Technologies and Proteomics II-14

Proteomics and Genomics II-15

Proteomics and Genomics: A Comparison II-15

Protein Production Pathway: From Gene Expression to

Functional Protein with Controls II-15

From Genomics to Proteomics II-16

Functional Genomics and Proteomics II-16

Push From Genomic Information II-17

An Insight into Proteomics Data Type and their

Characteristics / Features II-17

Standard Proteomics Approach II-17

Sample Preparation - Step I II-18

Protein Separation - Step II II-18

Protein Visualization II-18

Protein Expression Analysis-Step III II-18

Protein Identification - Step IV II-19

Data Storage and Processing - Step V II-19

 

4. OVERVIEW OF PROTEOMICS TECHNOLOGIES II-20

A Snapshot of Various Proteomics Tools II-20

An Insight into Various Proteomics Technologies and their

Application Areas II-20

Protein Separation II-20

2-Dimensional Gel Electrophoresis (2DGE) II-20

Protein Characterization II-22

Analysis of Protein Through Mass Spectrometry II-22

MS and Proteins II-22

Applications of MS II-23

Problems Associated with MS II-24

Types of Analyzers or Filters II-24

Y2H, Yeast 2-Hybrid System II-25

Protein Microarrays II-26

Chip Technology II-26

Microfluidic Applications II-27

Role of Bioinformatics in Proteomics II-27

Bioinformatics Applications and Tools in Proteomics II-27

Emerging Proteomics Technologies II-29

MudPIT II-29

ICAT II-29

Phage Display Technique II-30

Advanced Proteomics Technologies: Structural Analysis Tools II-30

X-ray Crystallography II-30

Nuclear Magnetic Resonance (NMR) II-30

In silico Modelling II-31

Physicochemical Factors Constraining Metabolic Functions II-31

 

5. END-USE APPLICATION AREAS II-32

Proteomics in Drug and Diagnostic Discovery II-33

Proteomics and Drug Discovery II-33

Protein Microarrays: A New Tool for the Development of

Pharmaceuticals II-34

Proteomic Approaches Gain Prominence in Cancer Drug Discovery II-34

Advancements in Proteomics Bring Biomarkers into Limelight II-35

 

6. NEW PRODUCT SOLUTIONS/ DEVELOPMENTS II-36

Applied Biomics Introduces Global Protein Post- Translational

Modification II-36

AB SCIEX Launches New Column Chips II-36

Applied Biomics Introduces New Mass Spectrometry Service II-37

Norton Scientific Introduces Novel Specialist Applications

Development Laboratory Service II-37

Gentel Biosciences Introduces APiXTM Disease Profiling Kit II-38

Integromics Introduces OmicsHub Proteomics 2.0 II-38

Bruker Introduces amaZon Speed Ion Trap Mass Spectrometers II-39

Applied Biomics Introduces iTRAQ Service for Proteomics Research II-39

Norton Scientifc Company Introduces New Lab Support Service

for Rapid RNA/DNA and Protein Measurement II-39

Bruker Launches MALDI BiotargetTM II-40

Thermo Fisher Launches UHLPC System II-40

Kinexus Introduces Human Gene Online TranscriptoNET KnowledgeBase II-41

Bruker Launches PRIME Integrated Proteomics Solution II-42

Applied Biosystems Launches LS*LIMS Laboratory Automation

Technology for Proteomics and Genomics II-42

Kinexus Bioinformatics Introduces Online KiNET-AM Proteomics

DataBase II-42

Bruker Rolls Out CaptiveSpray Electrospray Ion Source for

Proteomics Applications II-43

Thermo Fisher Launches New Capabilities for Performing

Proteomics Workflows II-43

National Cancer Institute Introduces Clinical Proteomic Tumor

Analysis Consortium for Cancer Studies II-44

KinaSorbTM' - New Kit for Kinase Enrichment II-45

 

7. PRODUCT INTRODUCTIONS/INNOVATIONS IN RECENT PAST - A

PERSPECTIVE BUILDER II-46

Gentel Biosciences Unveils Gentel Proteomics Multi-SystemTM II-46

caprotec bioanalytics Introduces Innovative caproKits II-46

Gentel Biosciences Introduces SilverQuant® Simian Pathogen

Array for Health Monitoring of Laboratory Animals II-46

Gentel Biosciences Introduces SilverQuant® Human Tumor

Profiling Kits II-46

Gentel Biosciences Introduces SilverQuant® Disease Profiling Kit II-47

Gentel Biosciences Introduces SilverQuant® View Detection Kits II-47

Gentel Biosciences Launches Proteomics Multi-System II-47

New England Peptide Introduces NEPTune™ Range of Proteomics

Reagents II-48

Applied Biomics Introduces NanoLC-MS/MS Service II-48

Life Technologies Introduces Magic Sample Processor for

Epigenetics, Proteomics Sample Preparation II-49

Integromics Introduces SeqSolve™ NGS Bioinformatics Analysis

Software II-50

Thermo Fisher Scientific Unveils Software Suite for Enhanced

Workflows in Proteomics II-50

Proxeon Introduces EASY-nLC II System for Improved

Productivity in Proteomics (Denmark) II-51

Gentel Biosciences Launches Proteomics Multi-System II-51

Arrayit Discovers New Proteomic Biomarkers II-52

Kinexus Bioinformatics Launches Peptide Development Facility II-52

Bruker Daltonics Unveils ultrafleXtreme™ MALDI-TOF/TOF Mass

Spectrometer II-52

Agilent Technologies Rolls Out HPLC-Chip II-53

Applied Biosystems and MDS Introduce AB SCIEX TOF/TOF™ 5800

System II-53

Applied Biomics Extends Proteomics Service Offerings II-54

AnaSpec Introduces Keratin Antibodies II-54

caprotec bioanalytics Unveils cAMP caproKit and SAH caproKit II-54

Huzhou Sai'erdi Biopharmaceutical Introduces Proteomic

Fingerprint Technology Test Kit II-54

 

8. RECENT INDUSTRY ACTIVITY II-55

Life Technologies Enters into Partnership with Sino Biological II-55

Proteome Sciences Signs Agreement with CHDI Foundation II-55

Waters Corp. Inks Agreement with Nonlinear Dynamics II-56

BioFocus Enters into Alliance with Activiomics II-56

Great Point Partners Divests Caprion Proteomics II-56

Glaxo Smith Kline Takes Over Cellzome II-57

Emerald BioSystems Changes Name to Emerald Bio II-57

Bruker Unveils Novel Nano-Advance UHPLC System II-57

Evotec Takes Over Kinaxo Biotechnologies II-58

Kinaxo Biotechnologies and AstraZeneca Sign Agreement II-58

Gentel Biosciences Takes Over Eppendorf's SilverQuant Trademark II-58

Thermo Fisher Takes Over Fermentas International II-58

KINAXO to Collaborate with Takeda II-59

Dualsystems and Bulldog Bio Signs Exclusive Marketing Agreement II-59

Novartis Enters into Agreement with SomaLogic II-59

Sage-N Inks Exclusive Pact With the U.S. Army II-59

Proteome Sciences Inks Agreement with Moffitt Cancer Center II-60

Gentel Biosciences Enters into Agreement with Oregon Health &

Science University II-60

Evotec OAI Forms Joint Venture with MeITec to Collaborate on

Drug Discovery Services II-60

 

9. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER II-61

MicroBioChips Merges with Biosystems II-61

Caprion Proteomics Acquires Biomarket Unit from PPD Biomarker

Discovery Sciences II-61

ICON Enters into Strategic Alliance with Proteome Sciences II-61

Gentel Enters into Partnership with RayBiotech for

SilverQuant® Chromogenic Detection Platform II-61

Trans-Hit Biomarkers Enters into Alliance with Caprion to

Deliver Proteome-Hit Services II-62

Proteoprep Enters into License Agreement with Sigma-Aldrich II-62

Activiomics Signs Technology Agreement with UCB for Proteomics

Platform(UK/Belgium) II-63

Expression Pathology Enters into Service Partnership with

Flagship for Tissue Proteomics Development II-63

National Cancer Institute Enters into MoU with AACC in

Proteomics Sector II-63

MGL Americas and ProFACT Proteomics Team Up for Biomarker

Discovery II-64

Thermo Fisher Scientific and Luxembourg Clinical Proteomics

Unit Form Collaboration (Luxembourg) II-64

Covance Unveils Discovery and Translational Services Division II-65

Thermo Fisher Scientific Takes Over Proxeon II-65

TriLink BioTechnologies and Nacalai USA Sign Distribution

Agreement II-65

Cell Biosciences Takes Over Alpha Innotech II-65

Eurogentec to Take Over Ana Spec II-66

Merck Takes Over Bangalore Genei II-66

Cell Biosciences Takes Over Protein Forest II-66

Microsoft to Acquire Rosetta Bio Software Assets II-67

CCMB and Bio-Rad India Sign MoU II-67

SAIC-Frederick and Sensor Technologies Ink Collaboration

Agreement II-67

NuSep Signs Purchase Agreement with BioInquire II-68

Intrinsic Bioprobes Bags Contract from NCI II-68

HORIBA Jobin Yvon Acquires GenOptics II-68

Gentel Biosciences Partners with Eprogen II-68

Bruker Daltonics Installs High-Field 15 Tesla and 12 Tesla

FTMS Systems at LUMC II-69

Genedata Extends Collaboration with Roche II-69

AliX Merges with Novalyst Discovery to form NovAliX II-70

BioPike and AnaSpec Sign Agreement II-70

Sigma-Aldrich Purchases Electrophoresis Business of NextGen

Sciences II-70

Fujifilm Purchases Additional Stake in Perseus Proteomics II-71

Sigma-Aldrich Buys Seppro® Depletion Technology and 700

Antibodies II-71

Oxford Gene Technology Purchases Sense Proteomic II-72

Center for Cancer Research Acquires Waters® UPLC/MS Systems II-72

 

10. FOCUS ON SELECT KEY PLAYERS II-74

ActivX Biosciences, Inc. (US) II-74

Adnexus Therapeutics (US) II-74

Agilent Technologies, Inc. (US) II-74

Bio-Rad Laboratories, Inc. II-74

Bruker Daltonics, Inc. (US) II-75

Caprion Proteomics, Inc. (Canada) II-75

Digilab Genomic Solutions, Inc. (US) II-76

Dionex Corporation (US) II-76

GE Healthcare (United Kingdom) II-76

Geneva Bioinformatics S.A. (Switzerland) II-76

Hybrigenics SA (France) II-76

Life Technologies Corporation (US) II-77

Millipore Corp. (US) II-77

PerkinElmer, Inc. (US) II-78

Caliper Life Sciences (US) II-78

Shimadzu Biotech (Japan) II-78

Sigma-Aldrich Corporation (US) II-78

Thermo Fisher Scientific (US) II-79

Waters Corp. (US) II-79

Xencor Inc. (US) II-80

Zyomyx, Inc. (US) II-80

 

11. GLOBAL MARKET PERSPECTIVE II-81

Table 1: World Recent Past, Current & Future Analysis for

Proteomics by Geographic Region - US, Canada, Japan, Europe

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) II-81

 

Table 2: World Historic Review for Proteomics by Geographic

Region - US, Canada, Japan, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) II-82

 

Table 3: World 15-Year Perspective for Proteomics by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe and Rest of World Markets for Years

2004, 2011 and 2018 (includes corresponding Graph/Chart) II-83

 

Table 4: World Recent Past, Current & Future Analysis for

Proteomics by Segment - Expression Proteomics, Functional

Proteomics and Structural Proteomics Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2010 through 2018 (includes corresponding Graph/Chart) II-84

 

Table 5: World Historic Review for Proteomics by Segment -

Expression Proteomics, Functional Proteomics and Structural

Proteomics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) II-85

 

Table 6: World 15-Year Perspective for Proteomics by Segment -

Percentage Breakdown of Dollar Sales for Expression

Proteomics, Functional Proteomics and Structural Proteomics

Markets for Years 2004, 2011 and 2018 (includes corresponding

Graph/Chart) II-86

 

12. GLOSSARY OF TERMS II-87

1-D, 2-D, 3-D II-87

Atmospheric Pressure Ionisation II-87

Electrophoresis II-87

Functional Genomics II-87

High-Throughput II-87

Liquid Chromatography (LC) II-87

Mass Spectrometry (MS) II-87

Matrix-Assisted Laser Desorption Ionisation (MALDI) II-87

Nuclear Magnetic Resonance II-88

X-ray Diffraction II-88

Yeast Two-Hybrid System II-88

2D-PAGE (Two-dimensional PolyAcrylamide Gel Electrophoresis) II-88

TOF (Time of Flight) II-88

Quadrupole II-88

Q-TOF (Quadrupole Time of Flight) II-88

ESI (Electrospray Ionisation) II-88

 

 

III. MARKET

 

1. THE UNITED STATES III-1

A.Market Analysis III-1

Outlook III-1

Proteomics Sample Preparation Market III-1

New Product Developments III-1

Strategic Corporate Developments III-6

Select Key Players III-9

B.Market Analytics III-14

Table 7: The US Recent Past, Current & Future Analysis for

Proteomics Market Analyzed with Annual Sales Figures in US$

Million for Years 2010 through 2018 (includes corresponding

Graph/Chart) III-14

 

Table 8: The US Historic Review for Proteomics Market

Analyzed with Annual Sales Figures in US$ Million for Years

2004 through 2009 (includes corresponding Graph/Chart) III-15

 

2. CANADA III-16

A.Market Analysis III-16

Outlook III-16

New Product Developments III-16

Strategic Corporate Development III-18

Caprion Proteomics, Inc. - A Key Player III-18

B.Market Analytics III-19

Table 9: Canadian Recent Past, Current & Future Analysis for

Proteomics Market Analyzed with Annual Sales Figures in US$

Million for Years 2010 through 2018 (includes corresponding

Graph/Chart) III-19

 

Table 10: Canadian Historic Review for Proteomics Market

Analyzed with Annual Sales Figures in US$ Million for Years

2004 through 2009 (includes corresponding Graph/Chart) III-20

 

3. JAPAN III-21

A.Market Analysis III-21

Shimadzu Biotech - A Key Player III-21

B.Market Analytics III-21

Table 11: Japanese Recent Past, Current & Future Analysis

for Proteomics Market Analyzed with Annual Sales Figures in

US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) III-21

 

Table 12: Japanese Historic Review for Proteomics Market

Analyzed with Annual Sales Figures in US$ Million for Years

2004 through 2009 (includes corresponding Graph/Chart) III-22

 

4. EUROPE III-23

A.Market Analysis III-23

Outlook III-23

Proteomics Research in Europe - An Overview III-23

Table 13: European Proteomics Market (2011): Percentage

Breakdown of Deployment of Proteomics Technologies in

End-Use Segments - Research and Academic Institutions,

Pharmaceutical Companies and Clinical Laboratories

(includes corresponding Graph/Chart) III-24

Protein Identification Market III-24

Protein Separation Market III-24

Market Challenges III-25

Gaining Edge in the Proteomics Industry - Player Strategies III-25

European 2DE Market - Benefiting from Recession III-26

Review of Select Markets III-26

Germany III-26

The United Kingdom III-26

New Product Developments III-27

Strategic Corporate Developments III-28

Select Key Players III-30

B.Market Analytics III-31

Table 14: European Recent Past, Current & Future Analysis

for Proteomics by Geographic Region - France, Germany, UK

and Rest of Europe Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2010 through

2018 (includes corresponding Graph/Chart) III-31

 

Table 15: European Historic Review for Proteomics by

Geographic Region - France, Germany, UK and Rest of Europe

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-32

 

Table 16: European 15-Year Perspective for Proteomics by

Geographic Region - Percentage Breakdown of Dollar Sales for

France, Germany, UK andRest of Europe Markets for Years

2004, 2011 and 2018 (includes corresponding Graph/Chart) III-33

 

5. REST OF WORLD III-34

A.Market Analysis III-34

Outlook III-34

Australia III-34

India III-34

Indian Scientific Research towards Functional Genomics and

Proteomics III-34

B.Market Analytics III-35

Table 17: Rest of World Recent Past, Current & Future

Analysis for Proteomics Market Analyzed with Annual Sales

Figures in US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) III-35

 

Table 18: Rest of World Historic Review for Proteomics

Market Analyzed with Annual Sales Figures in US$ Million for

Years 2004 through 2009 (includes corresponding Graph/Chart) III-36

 

 

IV. COMPETITIVE LANDSCAPE

 

Total Companies Profiled: 111 (including Divisions/Subsidiaries - 128)

 

The United States (82)

Canada (4)

Japan (3)

Europe (39)

- France (3)

- Germany (10)

- The United Kingdom (13)

- Spain (1)

- Rest of Europe (12)

 

 

 

To order this report:

Drug_Discovery_and_Development Industry: Global Proteomics Industry

 

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

 

 

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

@ThingsExpo Stories
Recently, REAN Cloud built a digital concierge for a North Carolina hospital that had observed that most patient call button questions were repetitive. In addition, the paper-based process used to measure patient health metrics was laborious, not in real-time and sometimes error-prone. In their session at 21st Cloud Expo, Sean Finnerty, Executive Director, Practice Lead, Health Care & Life Science at REAN Cloud, and Dr. S.P.T. Krishnan, Principal Architect at REAN Cloud, discussed how they built...
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...
In his session at 21st Cloud Expo, Raju Shreewastava, founder of Big Data Trunk, provided a fun and simple way to introduce Machine Leaning to anyone and everyone. He solved a machine learning problem and demonstrated an easy way to be able to do machine learning without even coding. Raju Shreewastava is the founder of Big Data Trunk (www.BigDataTrunk.com), a Big Data Training and consulting firm with offices in the United States. He previously led the data warehouse/business intelligence and B...
With tough new regulations coming to Europe on data privacy in May 2018, Calligo will explain why in reality the effect is global and transforms how you consider critical data. EU GDPR fundamentally rewrites the rules for cloud, Big Data and IoT. In his session at 21st Cloud Expo, Adam Ryan, Vice President and General Manager EMEA at Calligo, examined the regulations and provided insight on how it affects technology, challenges the established rules and will usher in new levels of diligence arou...
Nordstrom is transforming the way that they do business and the cloud is the key to enabling speed and hyper personalized customer experiences. In his session at 21st Cloud Expo, Ken Schow, VP of Engineering at Nordstrom, discussed some of the key learnings and common pitfalls of large enterprises moving to the cloud. This includes strategies around choosing a cloud provider(s), architecture, and lessons learned. In addition, he covered some of the best practices for structured team migration an...
The 22nd International Cloud Expo | 1st DXWorld Expo has announced that its Call for Papers is open. Cloud Expo | DXWorld Expo, to be held June 5-7, 2018, at the Javits Center in New York, NY, brings together Cloud Computing, Digital Transformation, Big Data, Internet of Things, DevOps, Machine Learning and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding busin...
No hype cycles or predictions of a gazillion things here. IoT is here. You get it. You know your business and have great ideas for a business transformation strategy. What comes next? Time to make it happen. In his session at @ThingsExpo, Jay Mason, an Associate Partner of Analytics, IoT & Cybersecurity at M&S Consulting, presented a step-by-step plan to develop your technology implementation strategy. He also discussed the evaluation of communication standards and IoT messaging protocols, data...
Smart cities have the potential to change our lives at so many levels for citizens: less pollution, reduced parking obstacles, better health, education and more energy savings. Real-time data streaming and the Internet of Things (IoT) possess the power to turn this vision into a reality. However, most organizations today are building their data infrastructure to focus solely on addressing immediate business needs vs. a platform capable of quickly adapting emerging technologies to address future ...
22nd International Cloud Expo, taking place June 5-7, 2018, at the Javits Center in New York City, NY, and co-located with the 1st DXWorld Expo will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud ...
22nd International Cloud Expo, taking place June 5-7, 2018, at the Javits Center in New York City, NY, and co-located with the 1st DXWorld Expo will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud ...
DevOps at Cloud Expo – being held June 5-7, 2018, at the Javits Center in New York, NY – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's largest enterprises – and delivering real results. Among the proven benefits,...
@DevOpsSummit at Cloud Expo, taking place June 5-7, 2018, at the Javits Center in New York City, NY, is co-located with 22nd Cloud Expo | 1st DXWorld Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait...
Cloud Expo | DXWorld Expo have announced the conference tracks for Cloud Expo 2018. Cloud Expo will be held June 5-7, 2018, at the Javits Center in New York City, and November 6-8, 2018, at the Santa Clara Convention Center, Santa Clara, CA. Digital Transformation (DX) is a major focus with the introduction of DX Expo within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive ov...
SYS-CON Events announced today that T-Mobile exhibited at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. As America's Un-carrier, T-Mobile US, Inc., is redefining the way consumers and businesses buy wireless services through leading product and service innovation. The Company's advanced nationwide 4G LTE network delivers outstanding wireless experiences to 67.4 million customers who are unwilling to compromise on qua...
SYS-CON Events announced today that Cedexis will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Cedexis is the leader in data-driven enterprise global traffic management. Whether optimizing traffic through datacenters, clouds, CDNs, or any combination, Cedexis solutions drive quality and cost-effectiveness. For more information, please visit https://www.cedexis.com.
SYS-CON Events announced today that Google Cloud has been named “Keynote Sponsor” of SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Companies come to Google Cloud to transform their businesses. Google Cloud’s comprehensive portfolio – from infrastructure to apps to devices – helps enterprises innovate faster, scale smarter, stay secure, and do more with data than ever before.
SYS-CON Events announced today that Vivint to exhibit at SYS-CON's 21st Cloud Expo, which will take place on October 31 through November 2nd 2017 at the Santa Clara Convention Center in Santa Clara, California. As a leading smart home technology provider, Vivint offers home security, energy management, home automation, local cloud storage, and high-speed Internet solutions to more than one million customers throughout the United States and Canada. The end result is a smart home solution that sav...
SYS-CON Events announced today that Opsani will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Opsani is the leading provider of deployment automation systems for running and scaling traditional enterprise applications on container infrastructure.
SYS-CON Events announced today that Nirmata will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Nirmata provides a comprehensive platform, for deploying, operating, and optimizing containerized applications across clouds, powered by Kubernetes. Nirmata empowers enterprise DevOps teams by fully automating the complex operations and management of application containers and its underlying ...
SYS-CON Events announced today that Opsani to exhibit at SYS-CON's 21st Cloud Expo, which will take place on October 31 through November 2nd 2017 at the Santa Clara Convention Center in Santa Clara, California. Opsani is creating the next generation of automated continuous deployment tools designed specifically for containers. How is continuous deployment different from continuous integration and continuous delivery? CI/CD tools provide build and test. Continuous Deployment is the means by which...